Suchergebnisse - "Kurti, Zsuzsanna"

PubPharm (8)

1

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort

enthalten in: Expert opinion on biological therapy | 2018

von Bálint, A. | Rutka, M. | Kolar, M. | +23

2

Progress with infliximab biosimilars for inflammatory bowel disease

enthalten in: Expert opinion on biological therapy | 2018

von Kurti, Z. | Gonczi, L. | Lakatos, P.

3

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

enthalten in: Inflammatory bowel diseases | 2017

von Gonczi, L. | Gecse, K. | Vegh, Z. | +23

4

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center

enthalten in: Expert opinion on biological therapy | 2017

von Farkas, K. | Rutka, M. | Ferenci, T. | +11

5

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases : results from Central European nationwide cohort

enthalten in: Expert opinion on drug safety | 2017

von Bálint, A. | Rutka, M. | Végh, Z. | +30

6

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

enthalten in: Journal of Crohn's & colitis | 2017

von Gonczi, L. | Vegh, Z. | Golovics, P. | +22

7

Real-Life Efficacy, Immunogenicity and Safety of Biosimilar Infliximab

enthalten in: Digestive diseases (Basel, Switzerland) | 2017

von Vegh, Z. | Kurti, Z. | Lakatos, P.

8

Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy : Results from two referral centres

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2014

von Mandel, M. | Balint, A. | Golovics, P. | +11

1
[1]